Elanco Animal Health (ELAN) Tops Q1 EPS by 14c, Offers FY and Q2 Guidance

Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.37, $0.14 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.16 billion.

GUIDANCE:

Elanco Animal Health sees FY2021 EPS of $1.00-$1.06, versus the consensus of $0.95. Elanco Animal Health sees FY2021 revenue of $4.68-4.73 billion, versus the consensus of $4.6 billion.

Elanco Animal Health sees Q2 2021 EPS of $0.22-$0.27, versus the consensus of $0.25. Elanco Animal Health sees Q2 2021 revenue of $1.23-1.26 billion, versus the consensus of $1.16 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance